Skip to main navigation Skip to search Skip to main content

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX4211 in Young Adult Patients with Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C

Project: Research

Project Details

StatusFinished
Effective start/end date05/1/15 → 04/30/21

Funding

  • Lexicon Pharmaceuticals Incorporated: $324,567.60